LATEST NEWS

main background

BIOMILLENIA partners with SOUFFLET on BIOprospect co-development of cellulolytic and proteolytic enzymes

Paris, France, December 1st, 2015—BIOMILLENIA SAS announces to partner with SOUFFLET BIOTECHNOLOGIES, a division of the french leading agricultural company SOUFFLET on co-developing novel enzymes within a BIOprospect project framework. BIOMILLENIA’s BIOprospect offering creates novel industry solutions for the manufacturing of biology-based products by exploring new enzymes and microbes from natural samples at unprecedented throughput. Ultrasensitive detection of enzyme activities …

main background

BIOMILLENIA launches the BIOMILLENIA DIMENSION 300X products for more efficient development of bio-based chemicals and natural products

Paris, France, September 24, 2015—BIOMILLENIA SAS today launched the new BIOMILLENIA DIMENSION 300X products for the development of bio-based chemicals and natural products. The product BIOprospect creates novel industry solutions for the manufacturing of bio-based chemicals by exploring new enzymes and microbes from natural samples at unprecedented throughput. Ultrasensitive detection of enzyme activities even allows the analysis of microbes that …

IPPG Building

Screen 30 million enzyme or strain variants in only a single day

Paris, France, September 10, 2015—BIOMILLENIA installed the second DIMENSION 300X platform, effectively doubling the company’s screening output to approximately 30.000.000 enzyme variants or microbial strains in a single day! Imagine what projects can be accomplished with such ultrahigh-throughput screening and assay capabilities. Let us know your ideas at info[at]biomillenia.com!